1589084-96-7

Upstream product

• 13958-93-5 3,5-dichloropyridine-4-carboxylic acid 
• 1589084-95-6 4-{5-chloro-2-[2-(2-fluorophenylamino)pyridin-4-yl]pyrido[3,4-d]pyrimidin-4-yl}piperazine-1-carboxylic acid tert-butyl ester 
• 411235-57-9 cyclopropylboronic acid 
• 1589084-87-6 C₁₂H₇Cl₃N₄O 
• 100859-84-5 2-chloro-4-pyridine carboxamide 
• 1589084-92-3 5-chloro-2-(2-chloropyridin-4-yl)pyrido[3,4-d]pyrimidin-4-ol 
• 1589084-93-4 4-[5-chloro-2-(2-chloropyridin-4-yl)pyrido[3,4-d]pyrimidin-4-yl]piperazine-1-carboxylic acid tert-butyl ester 
• 765224-12-2 2-chloropyridine-4-carboximidamide 

Downstream Products

• 1588952-76-4 [4-(5-cyclopropyl-4-piperazin-1-ylpyrido[3,4-d]pyrimidin-2-yl)pyridin-2-yl]-(2-fluorophenyl)amine 

Relevant academic research and scientific papers

Azaquinazoline Inhibitors Of Atypical Protein Kinase C

The present application provides a compound of formula (I) and/or a salt thereof, wherein R1, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disor

AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C

The present invention provides a compound of formula (I) or a salt thereof, wherein R7, R8, R9, G, and X are as defined herein. A compound of formula (I) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders.